Cost Effectiveness of Amphotericin B plus G-CSF Compared with Amphotericin B Monotherapy: Treatment of Presumed Deep-Seated Fungal Infection in Neutropenic Patients in the UK

Author： Flynn T.N.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.16, Iss.5, 1999-11, pp. : 543-550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic Patients

By Williams K.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 509-518

Adis International

Access to resources Recommend Favorite

Development of Novel Lyophilized Mixed Micelle Amphotericin B Formulation for Treatment of Systemic Fungal Infection

By  

Current Drug Delivery, Vol. 2, Iss. 2, 2005-04 ,pp. : 177-184

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections

By Kuti J.L.  

PharmacoEconomics, Vol. 22, Iss. 5, 2004-01 ,pp. : 301-310

Adis International

Access to resources Recommend Favorite

Amphotericin B lipid complex for the treatment of invasive fungal infections

By Linden Peter K  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 2099-2110

Informa Healthcare

Access to resources Recommend Favorite

Amphotericin B Lipid Complex in the Management of Invasive Fungal Infections in Immunocompromised Patients

By Bassetti Matteo  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 745-758

Adis International

Access to resources Recommend Favorite